Anthem shares soar to record high as insurer speeds pharmacy contract, issues rosy earnings outlook

Shares of health insurer Anthem soared to a record high Wednesday after it announced plans to roll out its new pharmacy benefits management unit IngenioRx sooner than expected and issued earnings guidance for this year that also beat forecasts. Anthem's shares soared as much as 12.2 percent to an all-time, intraday high of $305.99 a share.